PhaseV

PhaseV is a company specializing in causal machine learning (ML) technology for optimizing clinical trial design and analysis. PhaseV leverages advanced causal inference to detect hidden signals in clinical data and extract actionable insights to plan the best next steps. The company employs proprietary ML technology, empowering clinical development teams with advanced retrospective analysis and optimized study design capabilities while enabling real-time adjustments throughout the trial process. This ML-driven adaptive process accelerates the clinical drug development process, increases certainty during development, and enables more efficient, targeted, and successful clinical trials.